| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 57,55% | 80,80% | 80,05% | 201,81% |
| FIDELITY FUNDS-JAPAN GROWTH Y-ACC-EUR (HEDGED) | RVI JAPÓN | 32,63% | 77,04% | 80,05% | 250,36% |
| BLACKROCK SYSTEMATIC STYLE FACTOR IPF2 CHF HEDGED | RENT. ABSOLUTA. | 14,14% | 35,88% | 80,03% | · |
| INVESCO GLOBAL EQUITY INCOME A DIS ANNUAL EUR | RVI GLOBAL | 17,49% | 57,04% | 80,03% | 147,50% |
| WELLINGTON STRATEGIC EUROPEAN EQUITY FUND USD D ACC | RVI EUROPA CRECIMIENTO | 8,57% | 73,85% | 80,01% | · |
| AMUNDI FUNDS EQUITY JAPAN TARGET A EUR (C) | RVI JAPÓN | 31,90% | 67,56% | 79,95% | 123,72% |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I USD CAP | RVI EUROPA | 24,57% | 77,38% | 79,95% | · |
| POLAR CAPITAL GLOBAL INSURANCE I USD CAP | RVI FINANCIERO | 11,49% | 45,65% | 79,94% | 192,51% |
| ISHARES US INDEX FUND (IE) FLEXIBLE USD ACC | RVI USA | 18,44% | 65,76% | 79,93% | · |
| SCHRODER ISF GLOBAL RECOVERY A ACC USD | RVI GLOBAL | 28,69% | 60,63% | 79,93% | 149,31% |
| FTGF CLEARBRIDGE US APPRECIATION X EUR CAP | RVI USA | 23,95% | 68,50% | 79,91% | 248,59% |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I CHF CAP | RVI EUROPA | 25,16% | 77,53% | 79,91% | · |
| ROBECO QI EMERGING MARKETS 3D ACTIVE EQUITIES D EUR | RVI EMERGENTES | 39,90% | 91,27% | 79,90% | · |
| T.ROWE GLOBAL VALUE EQUITY FUND QDQ (GBP) | RVI GLOBAL VALOR | 36,52% | 71,92% | 79,89% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP EUR | RVI BIOTECNOLOGÍA | 58,92% | 80,47% | 79,87% | 199,60% |
| AMUNDI FUNDS EQUITY JAPAN TARGET A JPY (C) | RVI JAPÓN | 32,35% | 67,77% | 79,85% | 123,48% |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY EUR I ACC (HEDGED) | RVI TECNOLOGÍA | 52,98% | 177,40% | 79,83% | · |
| BNP PARIBAS RESPONSIBLE US VALUE MULTI-FACTOR EQUITY CLASSIC EUR CAP | RVI USA VALOR | 25,53% | 62,30% | 79,79% | · |
| VANGUARD U.S. 500 STOCK INDEX GENERAL USD CAP | RVI USA | 18,64% | 66,66% | 79,79% | 278,64% |
| VANGUARD U.S. 500 STOCK INDEX INVESTOR USD CAP | RVI USA | 18,64% | 66,66% | 79,79% | 276,85% |
